Injection

  Zepbound® (tirzepatide) is available in various dosages to meet individual treatment needs. The starting dose is typically 2.5 mg once weekly, used for the first four weeks to help the body adjust and minimize side effects. After this period, the dose is usually increased to 5 mg once weekly for improved glycemic control or weight management. If additional therapeutic effects are needed, the dosage can be further increased to 7.5 mg, followed by 10 mg, which is a common maintenance dose. For patients requiring more substantial effects, the dose may be adjusted to 12.5 mg, with 15 mg once weekly being the maximum recommended dosage for optimal blood sugar control or significant weight loss support. All dosing adjustments should be guided by a healthcare provider to ensure safety and efficacy. Ozempic is sold as an injectable solution, with each pen containing either 1.5 mL of solution. The medication is administered subcutaneously, typically in the abdomen, thigh, or upper arm2.